Non-hodgkin lymphoma
JO Armitage, RD Gascoyne, MA Lunning, F Cavalli - The lancet, 2017 - thelancet.com
Lymphomas can affect any organ in the body, present with a wide range of symptoms, and
be seen by primary care physicians and physicians from most specialties. They are …
be seen by primary care physicians and physicians from most specialties. They are …
CAR T-cell therapy for B-cell lymphomas: clinical trial results of available products
JC Chavez, C Bachmeier… - Therapeutic …, 2019 - journals.sagepub.com
Adoptive cellular immunotherapy with chimeric antigen receptor (CAR) T cell has changed
the treatment landscape of B-cell non-Hodgkin's lymphoma (NHL), especially for aggressive …
the treatment landscape of B-cell non-Hodgkin's lymphoma (NHL), especially for aggressive …
Artificial intelligence and COVID-19: deep learning approaches for diagnosis and treatment
COVID-19 outbreak has put the whole world in an unprecedented difficult situation bringing
life around the world to a frightening halt and claiming thousands of lives. Due to COVID …
life around the world to a frightening halt and claiming thousands of lives. Due to COVID …
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†☆
Diagnosis should be based on a surgical specimen/excisional lymph node (LN) biopsy.
Core biopsies should only be carried out in patients without easily accessible LNs (eg …
Core biopsies should only be carried out in patients without easily accessible LNs (eg …
Baseline metabolic tumor volume predicts outcome in high–tumor-burden follicular lymphoma: a pooled analysis of three multicenter studies
M Meignan, AS Cottereau, A Versari… - Journal of Clinical …, 2016 - ascopubs.org
Purpose Identifying patients at high risk of progression and early death among those with
high-tumor-burden follicular lymphoma (FL) is unsatisfactory with current prognostic models …
high-tumor-burden follicular lymphoma (FL) is unsatisfactory with current prognostic models …
FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas
SF Barrington, R Kluge - European journal of nuclear medicine and …, 2017 - Springer
Abstract PET using 18 F-FDG for treatment monitoring in patients with lymphoma is one of
the most well-developed clinical applications. PET/CT is nowadays used during treatment to …
the most well-developed clinical applications. PET/CT is nowadays used during treatment to …
Early event status informs subsequent outcome in newly diagnosed follicular lymphoma
Recent advances in follicular lymphoma (FL) have resulted in prolongation of overall
survival (OS). Here we assessed if early events as defined by event‐free survival (EFS) at 12 …
survival (OS). Here we assessed if early events as defined by event‐free survival (EFS) at 12 …
Time to prepare for risk adaptation in lymphoma by standardizing measurement of metabolic tumor burden
SF Barrington, M Meignan - Journal of Nuclear Medicine, 2019 - Soc Nuclear Med
Increased tumor burden is associated with inferior outcomes in many lymphoma subtypes.
Surrogates of tumor burden that are easy to measure, such as the maximum tumor …
Surrogates of tumor burden that are easy to measure, such as the maximum tumor …
A review of obinutuzumab (GA101), a novel type II anti-CD20 monoclonal antibody, for the treatment of patients with B-cell malignancies
K Tobinai, C Klein, N Oya, G Fingerle-Rowson - Advances in therapy, 2017 - Springer
Obinutuzumab (GA101) is a novel, type II, glycoengineered, humanized anti-CD20
monoclonal antibody that has been developed to address the need for new therapeutics …
monoclonal antibody that has been developed to address the need for new therapeutics …
PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study
SF Barrington, AA Kirkwood… - Blood, The Journal …, 2016 - ashpublications.org
International guidelines recommend that positron emission tomography-computed
tomography (PET-CT) should replace CT in Hodgkin lymphoma (HL). The aims of this study …
tomography (PET-CT) should replace CT in Hodgkin lymphoma (HL). The aims of this study …